Kinetics of large therapy doses of 131I in patients with thyroid cancer

Novel cAMP PDE III inhibitors: 1,6-naphthyridin-2(1H)-ones.

Journal of medicinal chemistry·1992

Presence of pulmonary intravascular macrophages in the equine lung: some structuro-functional properties.

The Anatomical record·1992

Evidence for immunodominance between closely related epitopes in the selection of T cell repertoire: hierarchy of T cell epitopes in a repeating sequence.

Molecular immunology·1992

Structure and hepatoprotective activity of a biflavonoid from Canarium manii.

Planta medica·1992

Seroprevalence of HIV infection in rural South Africa.

AIDS (London, England)·1992

The development of monoclonal antibodies to the human mitochondrial 60-kd heat-shock protein, and their use in studying the expression of the protein in rheumatoid arthritis.

Arthritis and rheumatism·1992

Patterns of Progression on Posttreatment Imaging During [177Lu]Lu-PSMA Radiopharmaceutical Therapy.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026

Impact of PSMA PET/CT Staging on Long-Term Outcomes in Patients with Clinically Localized Prostate Cancer: Results of a Large Single-Center Cohort.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026

Role of [18F]F-Fluciclovine PET/CT in Patients with Biochemical Recurrence of Prostate Cancer and Negative PSMA PET Results: A Single-Center Study.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026

18F-BMS-986192 PET to Predict Durable Response to Nivolumab in NSCLC: A Novel Approach Beyond PD-L1 Immunohistochemistry.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026

Botulinum Toxin Plus Transdermal Scopolamine Reduces Salivary Gland Uptake in Patients Undergoing Tandem Radiopharmaceutical Therapy with [225Ac]Ac- and [177Lu]Lu-PSMA Radioligands.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026

Predicting [90Y]Y-FAPI-46 Tumor Absorbed Dose from Single-Time-Point [68Ga]Ga-FAPI-46 PET/CT Imaging.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026

A cell-type resolved proton RBE model for potential clinical application.

Medical physics·2026

Three-fraction preoperative stereotactic radiotherapy for resectable brain metastases: the phase 2 STEP trial.

Neuro-oncology·2026

Adaptive MR-guided whole-pelvic SBRT with or without focal intraprostatic lesion boost for high-risk localized prostate Cancer: Adverse events and longitudinal quality-of-life outcomes.

Clinical and translational radiation oncology·2026

Development and validation of a cumulative risk model and assessment tool for radiation-induced hypothyroidism in head and neck cancer: a multicentre study.

Clinical and translational radiation oncology·2026

Radiation therapy quality assurance (RT QA) of adjuvant fractionated radiotherapy for WHO grade 2 atypical meningioma in the ROAM/EORTC1308 trial.

Clinical and translational radiation oncology·2026

Radiotherapy-induced oxidative stress and mitochondrial dysfunction: potential contributions of toxic elements and associated biomarkers-a systematic review.

Frontiers in public health·2026

Kinetics of large therapy doses of 131I in patients with thyroid cancer

Related Experiment Videos

Related Concept Videos

Novel cAMP PDE III inhibitors: 1,6-naphthyridin-2(1H)-ones.

Presence of pulmonary intravascular macrophages in the equine lung: some structuro-functional properties.

Evidence for immunodominance between closely related epitopes in the selection of T cell repertoire: hierarchy of T cell epitopes in a repeating sequence.

Structure and hepatoprotective activity of a biflavonoid from Canarium manii.

Seroprevalence of HIV infection in rural South Africa.

The development of monoclonal antibodies to the human mitochondrial 60-kd heat-shock protein, and their use in studying the expression of the protein in rheumatoid arthritis.

Patterns of Progression on Posttreatment Imaging During [177Lu]Lu-PSMA Radiopharmaceutical Therapy.

Impact of PSMA PET/CT Staging on Long-Term Outcomes in Patients with Clinically Localized Prostate Cancer: Results of a Large Single-Center Cohort.

Role of [18F]F-Fluciclovine PET/CT in Patients with Biochemical Recurrence of Prostate Cancer and Negative PSMA PET Results: A Single-Center Study.

18F-BMS-986192 PET to Predict Durable Response to Nivolumab in NSCLC: A Novel Approach Beyond PD-L1 Immunohistochemistry.

Botulinum Toxin Plus Transdermal Scopolamine Reduces Salivary Gland Uptake in Patients Undergoing Tandem Radiopharmaceutical Therapy with [225Ac]Ac- and [177Lu]Lu-PSMA Radioligands.

Predicting [90Y]Y-FAPI-46 Tumor Absorbed Dose from Single-Time-Point [68Ga]Ga-FAPI-46 PET/CT Imaging.

A cell-type resolved proton RBE model for potential clinical application.

Three-fraction preoperative stereotactic radiotherapy for resectable brain metastases: the phase 2 STEP trial.

Adaptive MR-guided whole-pelvic SBRT with or without focal intraprostatic lesion boost for high-risk localized prostate Cancer: Adverse events and longitudinal quality-of-life outcomes.

Development and validation of a cumulative risk model and assessment tool for radiation-induced hypothyroidism in head and neck cancer: a multicentre study.

Radiation therapy quality assurance (RT QA) of adjuvant fractionated radiotherapy for WHO grade 2 atypical meningioma in the ROAM/EORTC1308 trial.

Radiotherapy-induced oxidative stress and mitochondrial dysfunction: potential contributions of toxic elements and associated biomarkers-a systematic review.

Kinetics of large therapy doses of 131I in patients with thyroid cancer

Related Experiment Videos

Related Concept Videos

Related Articles